title: Pretreatments with a novel pure potassium channel blocker, Nifekalant, were effective in the electrical atrial defibrillation: a report of two cases.
authors.affiliation: Department of Cardiovascular Medicine, Japanese Red Cross Medical Center, Tokyo.
authors.forename: Gaku
authors.initials: G
authors.lastname: Sekita
authors.forename: Daigo
authors.initials: D
authors.lastname: Sawaki
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Otani
authors.forename: Naoshi
authors.initials: N
authors.lastname: Kobayakawa
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Fukushima
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Teruhiko
authors.initials: T
authors.lastname: Aoyagi
mesh_terms: D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000628:therapy*; D003131:Combined Modality Therapy; D017147:Defibrillators, Implantable; D004554:Electric Countershock; D005260:Female; D006801:Humans; D008297:Male; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000627:therapeutic use*
chemical_list: D000889:Anti-Arrhythmia Agents; D026902:Potassium Channel Blockers; D011744:Pyrimidinones; C076259:nifekalant